Re: Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

被引：0
|
作者：
Chang, Sam S.
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [1] Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
    Powles, Thomas
    Rosenberg, Jonathan E.
    Sonpavde, Guru P.
    Loriot, Yohann
    Duran, Ignacio
    Lee, Jae-Lyun
    Matsubara, Nobuaki
    Vulsteke, Christof
    Castellano, Daniel
    Wu, Chunzhang
    Campbell, Mary
    Matsangou, Maria
    Petrylak, Daniel P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1125 - 1135
  • [2] Cost-effectiveness of enfortumab vedotin in previously treated advanced urothelial carcinoma
    Wu, Qiuji
    Qin, Yi
    Liao, Weiting
    Zhang, Mengxi
    Yang, Yang
    Zhang, Pengfei
    Li, Qiu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [3] Enfortumab Vedotin in Advanced Urothelial Carcinoma
    Petrylak, Daniel P.
    Powles, Thomas
    Rosenberg, Jonathan E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (01): : 93 - 94
  • [4] Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China
    Li, Siming
    Shi, Yanxia
    Dong, Haiying
    Guo, Hongqian
    Xie, Yu
    Sun, Zhongquan
    Zhang, Xiaoping
    Kim, Eric
    Zhang, Jun
    Li, Yue
    Xu, Chenming
    Kadeerbai, Haishan
    Lee, Sue
    Gorla, Seema
    Guo, Jun
    Sheng, Xinan
    CANCER MEDICINE, 2024, 13 (21):
  • [5] Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
    Catalano, Martina
    Santoni, Matteo
    Roviello, Giandomenico
    EUROPEAN UROLOGY, 2024, 86 (03) : 283 - 283
  • [6] EV-203: Phase 2 trial of enfortumab vedotin in patients with previously treated advanced urothelial carcinoma in China
    Li, Siming
    Shi, Yanxia
    Dong, Haiying
    Guo, Hongqian
    Li, Yue
    Kadeerbai, Haishan
    Xu, Chenming
    Kim, Eric
    Lee, Sue
    Gorla, Seema Rao
    Zhang, Jun
    Guo, Jun
    Sheng, Xinan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
    Hoimes, Christopher J.
    Flaig, Thomas W.
    Milowsky, Matthew, I
    Friedlander, Terence W.
    Bilen, Mehmet Asim
    Gupta, Shilpa
    Srinivas, Sandy
    Merchan, Jaime R.
    McKay, Rana R.
    Petrylak, Daniel P.
    Sasse, Carolyn
    Moreno, Blanca Homet
    Yu, Yao
    Carret, Anne-Sophie
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (01) : 22 - +
  • [8] Enfortumab vedotin-ejfv for the treatment of advanced urothelial carcinoma
    Mantia, Charlene M.
    Sonpavde, Guru
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (05) : 449 - 455
  • [9] Enfortumab vedotin to treat urothelial carcinoma
    Hanna, K. S.
    DRUGS OF TODAY, 2020, 56 (05) : 329 - 335
  • [10] A CASE OF ENFORTUMAB VEDOTIN TOXICITY IN A PATIENT WITH ADVANCED UROTHELIAL CELL CARCINOMA
    Grigsby, Charles
    Thebert, Alexander
    Pijut, Kyle
    Woodward, Blake
    Bastin, Melissa Thompson
    Soper, Melissa
    Fozzard, Andrew
    CRITICAL CARE MEDICINE, 2024, 52
12345